1-17 of 17
hnf1a gene
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comment on Misra et al. Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912

Hui-Xuan Wu, Long Li, Hou-De Zhou
Journal: Diabetes Care
Diabetes Care 2020;43(10):e154
https://doi.org/10.2337/dc20-1142
Published: 11 September 2020
View article titled, Comment on Misra et al. Homozygous Hypomorphic <em>HNF1A</em> Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912
Open the PDF for Comment on Misra et al. Homozygous Hypomorphic <em>HNF1A</em> Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912 in another window
Journal Articles

Response to Comment on Misra et al. Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912

Shivani Misra, Neelam Hassanali, Amanda J. Bennett, Agata Juszczak, Richard Caswell, Kevin Colclough, Jonathan Valabhji, Sian Ellard, Nicholas S. Oliver, Anna L. Gloyn
Journal: Diabetes Care
Diabetes Care 2020;43(10):e155–e156
https://doi.org/10.2337/dci20-0033
Published: 11 September 2020
View article titled, Response to Comment on Misra et al. Homozygous Hypomorphic <em>HNF1A</em> Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912
Open the PDF for Response to Comment on Misra et al. Homozygous Hypomorphic <em>HNF1A</em> Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912 in another window
Journal Articles

Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)

Alexander S. Christensen, Sofie Hædersdal, Julie Støy, Heidi Storgaard, Ulla Kampmann, Julie L. Forman, Marta Seghieri, Jens J. Holst, Torben Hansen, Filip K. Knop, Tina Vilsbøll
Journal: Diabetes Care
Diabetes Care 2020;43(9):2025–2033
https://doi.org/10.2337/dc20-0408
Published: 13 July 2020
View article titled, Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)
Open the PDF for Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA) in another window
Journal Articles

Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes

Shivani Misra, Neelam Hassanali, Amanda J. Bennett, Agata Juszczak, Richard Caswell, Kevin Colclough, Jonathan Valabhji, Sian Ellard, Nicholas S. Oliver, Anna L. Gloyn
Journal: Diabetes Care
Diabetes Care 2020;43(4):909–912
https://doi.org/10.2337/dc19-1843
Published: 30 January 2020
View article titled, Homozygous Hypomorphic <em>HNF1A</em> Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes
Open the PDF for Homozygous Hypomorphic <em>HNF1A</em> Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes in another window
Includes: Supplementary data
Journal Articles

The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing

Matthew S. GoodSmith, M. Reza Skandari, Elbert S. Huang, Rochelle N. Naylor
Journal: Diabetes Care
Diabetes Care 2019;42(12):2247–2255
https://doi.org/10.2337/dc19-0486
Published: 26 September 2019
View article titled, The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing
Open the PDF for The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing in another window
Includes: Supplementary data
Journal Articles

Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult–Onset Nonautoimmune Diabetes

Agata Juszczak, Tamara Pavić, Frano Vučković, Amanda J. Bennett, Neha Shah, Edita Pape Medvidović, Christopher J. Groves, Mario Šekerija, Kyla Chandler, Carla Burrows, Nataša Rojnić Putarek, Marijana Vučić Lovrenčić, Jadranka Ćuća Knežević, Tim J. James, Anna L. Gloyn, Gordan Lauc, Mark I. McCarthy, Katharine R. Owen, Olga Gornik
Journal: Diabetes Care
Diabetes Care 2019;42(1):17–26
https://doi.org/10.2337/dc18-0422
Published: 19 November 2018
View article titled, Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult–Onset Nonautoimmune Diabetes
Open the PDF for Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult–Onset Nonautoimmune Diabetes in another window
Includes: Supplementary data
Journal Articles

Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas

Alexandro J. Martagón, Omar Yaxmehen Bello-Chavolla, Olimpia Arellano-Campos, Paloma Almeda-Valdés, Geoffrey A. Walford, Ivette Cruz-Bautista, Donají V. Gómez-Velasco, Roopa Mehta, Liliana Muñoz-Hernández, Magdalena Sevilla-González, Tannia L. Viveros-Ruiz, María Luisa Ordoñez-Sánchez, Rosario Rodríguez-Guillen, Jose C. Florez, María Teresa Tusié-Luna, Carlos A. Aguilar-Salinas, Slim Initiative in Genomic Medicine for the Americas (SIGMA) Type 2 Diabetes Consortium, Josep M. Mercader, Alicia Huerta-Chagoya, Hortensia Moreno-Macías, Humberto García-Ortiz, Alisa Manning, Lizz Caulkins, Jason Flannick, Nick Patterson, Angélica Martínez-Hernández, Federico Centeno-Cruz, Francisco Martin Barajas-Olmos, Carlos Zerrweck, Cecilia Contreras-Cubas, Elvia Mendoza-Caamal, Cristina Revilla-Monsalve, Sergio Islas Andrade, Emilio Córdova, Xavier Soberón, María Elena González-Villalpando, Lynne Wilkens, Loic Le Marchand, Kristine Monroe, Laurence Kolonel, Olimpia Arellano-Campos, María L. Ordóñez-Sánchez, Maribel Rodríguez-Torres, Yayoi Segura-Kato, Rosario Rodríguez-Guillén, Ivette Cruz-Bautista, Linda Liliana Muñoz-Hernández, Alexandro J. Martagón, Magdalena del Rocio Sevilla Gonzalez, Donají Gómez, Paloma Almeda-Valdés, Maria Eugenia Garay, Juan Manuel Malacara Hernandez, Noël P. Burtt, Maria L. Cortes, David M. Altshuler, Christopher A. Haiman, Carlos A. Aguilar-Salinas, Clicerio González-Villalpando, Lorena Orozco, Teresa Tusié-Luna, Jose C. Florez
Journal: Diabetes Care
Diabetes Care 2018;41(8):1726–1731
https://doi.org/10.2337/dc18-0384
Published: 29 May 2018
View article titled, Mexican Carriers of the <em>HNF1A</em> p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas
Open the PDF for Mexican Carriers of the <em>HNF1A</em> p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas in another window
Includes: Supplementary data
Journal Articles

Low Prevalence of HNF1A Mutations After Molecular Screening of Multiple MODY Genes in 58 Italian Families Recruited in the Pediatric or Adult Diabetes Clinic From a Single Italian Hospital

Maurizio Delvecchio, Ornella Ludovico, Claudia Menzaghi, Rosa Di Paola, Leopoldo Zelante, Antonella Marucci, Valeria Grasso, Vincenzo Trischitta, Massimo Carella, Fabrizio Barbetti
Journal: Diabetes Care
Diabetes Care 2014;37(12):e258–e260
https://doi.org/10.2337/dc14-1788
Published: 08 November 2014
View article titled, Low Prevalence of <em>HNF1A</em> Mutations After Molecular Screening of Multiple MODY Genes in 58 Italian Families Recruited in the Pediatric or Adult Diabetes Clinic From a Single Italian Hospital
Open the PDF for Low Prevalence of <em>HNF1A</em> Mutations After Molecular Screening of Multiple MODY Genes in 58 Italian Families Recruited in the Pediatric or Adult Diabetes Clinic From a Single Italian Hospital in another window
Journal Articles

Glucose-Lowering Effects and Low Risk of Hypoglycemia in Patients With Maturity-Onset Diabetes of the Young When Treated With a GLP-1 Receptor Agonist: A Double-Blind, Randomized, Crossover Trial

Signe H. Østoft, Jonatan I. Bagger, Torben Hansen, Oluf Pedersen, Jens Faber, Jens J. Holst, Filip K. Knop, Tina Vilsbøll
Journal: Diabetes Care
Diabetes Care 2014;37(7):1797–1805
https://doi.org/10.2337/dc13-3007
Published: 12 June 2014
View article titled, Glucose-Lowering Effects and Low Risk of Hypoglycemia in Patients With Maturity-Onset Diabetes of the Young When Treated With a GLP-1 Receptor Agonist: A Double-Blind, Randomized, Crossover Trial
Open the PDF for Glucose-Lowering Effects and Low Risk of Hypoglycemia in Patients With Maturity-Onset Diabetes of the Young When Treated With a GLP-1 Receptor Agonist: A Double-Blind, Randomized, Crossover Trial in another window
Includes: Supplementary data
Journal Articles

Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications

Rochelle N. Naylor, Priya M. John, Aaron N. Winn, David Carmody, Siri Atma W. Greeley, Louis H. Philipson, Graeme I. Bell, Elbert S. Huang
Journal: Diabetes Care
Diabetes Care 2014;37(1):202–209
https://doi.org/10.2337/dc13-0410
Published: 11 December 2013
View article titled, Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
Open the PDF for Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications in another window
Includes: Supplementary data
Journal Articles

Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration: Is it time to change the diagnostic criteria for MODY?

Stepanka Pruhova, MD, Petra Dusatkova, PHD, David Neumann, MD, Erik Hollay, MD, Ondrej Cinek, MD, Jan Lebl, MD, Zdenek Sumnik, MD
Journal: Diabetes Care
Diabetes Care 2013;36(9):2573–2574
https://doi.org/10.2337/dc13-0058
Published: 13 August 2013
View article titled, Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration: <subtitle>Is it time to change the diagnostic criteria for MODY?</subtitle>
Open the PDF for Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration: <subtitle>Is it time to change the diagnostic criteria for MODY?</subtitle> in another window
Journal Articles

Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young

Gaya Thanabalasingham, BM, Aparna Pal, BM, Mary P. Selwood, MSC, Christina Dudley, RGN, Karen Fisher, Polly J. Bingley, MD, Sian Ellard, PHD, Andrew J. Farmer, DM, Mark I. McCarthy, MD, Katharine R. Owen, MD
Journal: Diabetes Care
Diabetes Care 2012;35(6):1206–1212
https://doi.org/10.2337/dc11-1243
Published: 11 May 2012
View article titled, Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young
Open the PDF for Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young in another window
Includes: Supplementary data
Journal Articles

Double Heterozygous Germline HNF1A Mutations in a Patient With Liver Adenomatosis

Emmanuelle Jeannot, PHD, Geneviève Lacape, MD, Henri Gin, MD, Gabrielle Couchy, ENGINEER, Jean Saric, MD, Hervé Laumonier, MD, Brigitte Le Bail, MD, Paulette Bioulac-Sage, MD, Charles Balabaud, MD, Jessica Zucman-Rossi, MD, PHD
Journal: Diabetes Care
Diabetes Care 2012;35(5):e35
https://doi.org/10.2337/dc12-0030
Published: 11 April 2012
View article titled, Double Heterozygous Germline HNF1A Mutations in a Patient With Liver Adenomatosis
Open the PDF for Double Heterozygous Germline HNF1A Mutations in a Patient With Liver Adenomatosis in another window
Journal Articles

Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes: A case report

Gabriele Forlani, MD, Stefano Zucchini, MD, Antonio Di Rocco, DSC, Raffaella Di Luzio, MD, Mirella Scipione, MD, Elena Marasco, DSC, Giovanni Romeo, MD, Giulio Marchesini, MD, Vilma Mantovani, DSC, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(11):2336–2338
https://doi.org/10.2337/dc10-0561
Published: 12 August 2010
View article titled, Double Heterozygous Mutations Involving Both <em>HNF1A</em>/MODY3 and <em>HNF4A</em>/MODY1 Genes: <subtitle>A case report</subtitle>
Open the PDF for Double Heterozygous Mutations Involving Both <em>HNF1A</em>/MODY3 and <em>HNF4A</em>/MODY1 Genes: <subtitle>A case report</subtitle> in another window
Includes: Supplementary data
Journal Articles

Maturity-Onset Diabetes of the Young in Children With Incidental Hyperglycemia:: A multicenter Italian study of 172 families

Renata Lorini, MD, Catherine Klersy, MD, Giuseppe d'Annunzio, MD, Ornella Massa, PHD, Nicola Minuto, MD, Dario Iafusco, MD, Christine Bellannè-Chantelot, Anna Paola Frongia, MD, Sonia Toni, MD, Franco Meschi, MD, Franco Cerutti, MD, Fabrizio Barbetti, MD, the Italian Society of Pediatric Endocrinology and Diabetology (ISPED) Study Group
Journal: Diabetes Care
Diabetes Care 2009;32(10):1864–1866
https://doi.org/10.2337/dc08-2018
Published: 06 June 2009
View article titled, Maturity-Onset Diabetes of the Young in Children With Incidental Hyperglycemia:: <subtitle>A multicenter Italian study of 172 families</subtitle>
Open the PDF for Maturity-Onset Diabetes of the Young in Children With Incidental Hyperglycemia:: <subtitle>A multicenter Italian study of 172 families</subtitle> in another window
Includes: Supplementary data
Meeting Abstracts

Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians.

R A Hegele, H Cao, A J Hanley, B Zinman, S B Harris, C M Anderson
Journal: Diabetes Care
Diabetes Care 2000;23(6):775–778
https://doi.org/10.2337/diacare.23.6.775
Published: 01 June 2000
View article titled, Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians.
Open the PDF for Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. in another window
Meeting Abstracts

Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians.

R A Hegele, A J Hanley, B Zinman, S B Harris, C M Anderson
Journal: Diabetes Care
Diabetes Care 1999;22(12):2095–2096
https://doi.org/10.2337/diacare.22.12.2095
Published: 01 December 1999
View article titled, Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians.
Open the PDF for Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians. in another window